These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Screening for prostate cancer: current recommendations. Wilson SS; Crawford ED Urol Clin North Am; 2004 May; 31(2):219-26. PubMed ID: 15123402 [TBL] [Abstract][Full Text] [Related]
5. PSA-based screening for prostate cancer: how does it compare with other cancer screening tests? Crawford ED; Abrahamsson PA Eur Urol; 2008 Aug; 54(2):262-73. PubMed ID: 18556114 [TBL] [Abstract][Full Text] [Related]
9. Prostate cancer. When to offer screening in the primary care setting. Gambert SR Geriatrics; 2001 Jan; 56(1):22-6, 29-31. PubMed ID: 11196336 [TBL] [Abstract][Full Text] [Related]
10. How to use PSA to screen for prostate cancer. Little B; Young M Int J Clin Pract; 2003; 57(1):40-2. PubMed ID: 12587941 [TBL] [Abstract][Full Text] [Related]
11. Impact of improvement in specificity of primary screening test on total cost of prostate cancer mass screening. Kobayashi T; Goto R; Fukui T; Ogawa O Int J Urol; 2007 Sep; 14(9):805-10. PubMed ID: 17760746 [TBL] [Abstract][Full Text] [Related]
12. Percent free PSA as an additional measure in a prostate cancer screen. Miele ME Clin Lab Sci; 2001; 14(2):102-7. PubMed ID: 15625982 [TBL] [Abstract][Full Text] [Related]
13. Interval cancers in prostate cancer screening: comparing 2- and 4-year screening intervals in the European Randomized Study of Screening for Prostate Cancer, Gothenburg and Rotterdam. Roobol MJ; Grenabo A; Schröder FH; Hugosson J J Natl Cancer Inst; 2007 Sep; 99(17):1296-303. PubMed ID: 17728218 [TBL] [Abstract][Full Text] [Related]
14. [Prostate cancer and prostate specific antigen screening]. Camici M Minerva Med; 2004 Feb; 95(1):25-34. PubMed ID: 15041924 [TBL] [Abstract][Full Text] [Related]
15. Screening for prostate cancer. Brawley OW; Ankerst DP; Thompson IM CA Cancer J Clin; 2009; 59(4):264-73. PubMed ID: 19564245 [TBL] [Abstract][Full Text] [Related]
16. [Prostate tumor and its diagnosis]. Yamanaka H Rinsho Byori; 2001 Jul; 49(7):633-7. PubMed ID: 11519121 [TBL] [Abstract][Full Text] [Related]
17. Specificity of serum prostate-specific antigen determination in the Finnish prostate cancer screening trial. Määttänen L; Hakama M; Tammela TL; Ruutu M; Ala-Opas M; Juusela H; Martikainen P; Stenman UH; Auvinen A Br J Cancer; 2007 Jan; 96(1):56-60. PubMed ID: 17213825 [TBL] [Abstract][Full Text] [Related]
18. [Early detection of cancer of the prostate. Pros and cons]. Hoesl CE; Altwein JE MMW Fortschr Med; 2005 Apr; 147(14):32, 34-6. PubMed ID: 15887681 [TBL] [Abstract][Full Text] [Related]
19. Cancer screening in the United States, 2009: a review of current American Cancer Society guidelines and issues in cancer screening. Smith RA; Cokkinides V; Brawley OW CA Cancer J Clin; 2009; 59(1):27-41. PubMed ID: 19147867 [TBL] [Abstract][Full Text] [Related]
20. Prostate cancer and prostate-specific antigen (PSA) screening in Austria. Vutuc C; Schernhammer ES; Haidinger G; Waldhör T Wien Klin Wochenschr; 2005 Jul; 117(13-14):457-61. PubMed ID: 16091872 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]